Exploring molecular phenotypes of incident breast cancer through population-based proteogenomics

This free webinar will focus on exploring the power of proteomic discoveries, at the population scale in a breast cancer cohort, and the integration of proteogenomics to generate key biological insights into risk prediction that may lead to translational applications for breast cancer prevention.

Join this expert webinar to learn more about:

  • The importance of integrating multi-omics at a systemic level to generate key biological insights for cancer prevention, diagnosis, and treatment
  • Emerging large-scale cancer proteomics analyses at the population level
  • Using high-throughput proteomics to find actionable biomarkers to better understand and treat human cancer.

Presenter: Dr. Anders Mälarstig

Director of Target Sciences, Pfizer Worldwide Research and Development


Biomarker assays

~475 million

Protein data points generated


Publications listed on website


Certified Core Labs

Contact us!